PMID- 16730570 OWN - NLM STAT- MEDLINE DCOM- 20060711 LR - 20071115 IS - 1557-3117 (Electronic) IS - 1053-2498 (Linking) VI - 25 IP - 6 DP - 2006 Jun TI - Prognostic stratification of women with chronic heart failure referred for heart transplantation: relevance of gender as compared with gender-related characteristics. PG - 648-52 AB - BACKGROUND: Few studies are available regarding prognostic stratification of women with severe chronic heart failure (CHF). Although women seem to have a better outcome than men, this may be due to favorable baseline characteristics. METHODS: We analyzed a cohort of CHF patients referred for heart transplantation (HT) who underwent clinical/laboratory/instrumental evaluation. Women and men were frequency matched for baseline age (53 +/- 14 vs 53 +/- 9 years, p = 0.92), left ventricular ejection fraction (33 +/- 10 vs 31 +/- 8%, p = 0.90) and ischemic etiology (17 vs 22%, p = 0.50). RESULTS: A total of 198 patients were analyzed (109 women matched to 89 men). In addition to matching parameters, prevalence of severe symptoms, diabetes and hypertension were also comparable (p > or = 0.25). After 3 years, cardiovascular death or need for HT (CD/HT) event-free survival was 78 +/- 4% in women and 50 +/- 6% in men (p = 0.005). On multivariate analysis, female gender was associated with a lower risk of CD/HT (relative risk [RR] 0.52; 95% confidence interval [CI] 0.30 to 0.89; p = 0.017), independently of symptoms, blood pressure (BP), left ventricular end-diastolic diameter (LVEDD) and mitral regurgitation (MR). Nevertheless, CD/HT event-free survival at 3 years was 49 +/- 9% for women with New York Heart Association (NYHA) Class III or IV status, who presented with either severe MR, mean BP < or =60 mm Hg or LVEDD > or =35 mm/m2. CONCLUSIONS: In advanced CHF, women patients seem to have a better prognosis irrespective of baseline characteristics, supporting the hypothesis that female gender is protective against myocardial injury. However, women with severe symptoms accompanied by either hypotension, severe left ventricular enlargement or MR are at high risk and deserve cautious follow-up and consideration for HT. FAU - Grigioni, Francesco AU - Grigioni F AD - Cardiology Institute, University of Bologna, Bologna, Italy. francesco.grigioni@unibo.it FAU - Barbieri, Andrea AU - Barbieri A FAU - Russo, Antonio AU - Russo A FAU - Reggianini, Letizia AU - Reggianini L FAU - Bonatti, Silvia AU - Bonatti S FAU - Potena, Luciano AU - Potena L FAU - Fabbri, Francesca AU - Fabbri F FAU - Coccolo, Fabio AU - Coccolo F FAU - Magnani, Gaia AU - Magnani G FAU - Bursi, Francesca AU - Bursi F FAU - Magelli, Carlo AU - Magelli C FAU - Modena, Maria G AU - Modena MG FAU - Branzi, Angelo AU - Branzi A LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20060502 PL - United States TA - J Heart Lung Transplant JT - The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation JID - 9102703 SB - IM MH - Adult MH - Aged MH - Female MH - Heart Failure/drug therapy/*mortality/*surgery MH - Heart Transplantation MH - Humans MH - Male MH - Middle Aged MH - Multivariate Analysis MH - Prognosis MH - Sex Factors MH - Survival Analysis MH - Treatment Outcome EDAT- 2006/05/30 09:00 MHDA- 2006/07/13 09:00 CRDT- 2006/05/30 09:00 PHST- 2005/08/04 00:00 [received] PHST- 2005/10/10 00:00 [revised] PHST- 2006/02/11 00:00 [accepted] PHST- 2006/05/30 09:00 [pubmed] PHST- 2006/07/13 09:00 [medline] PHST- 2006/05/30 09:00 [entrez] AID - S1053-2498(06)00157-4 [pii] AID - 10.1016/j.healun.2006.02.004 [doi] PST - ppublish SO - J Heart Lung Transplant. 2006 Jun;25(6):648-52. doi: 10.1016/j.healun.2006.02.004. Epub 2006 May 2.